I agree that this site is using cookies. You can find further informations here.
X
Hodi, F. Stephen
516  results:
Search for persons X
?
1

Phase II trial of vaccination with autologous, irradiated m..:

Sussman, Tamara A. ; Severgnini, Mariano ; Giobbie-Hurder, Anita...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523)..:

Buchbinder, Elizabeth I. ; Cohen, Justine V. ; Tarantino, Giuseppe...
Cancer Research Communications.  4 (2024)  5 - p. 1321-1327 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Ziv-aflibercept plus pembrolizumab in patients with advance..:

Baginska, Joanna ; Nau, Allison ; Gomez Diaz, Ilana...
Cancer Immunology, Immunotherapy.  73 (2024)  1 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

Transmural Flow Upregulates PD‐L1 Expression in Microvascul..:

Wan, Zhengpeng ; Zhang, Shun ; Zhong, Amy X....
Advanced Science.  , 2024
Link: https://doi.org/10.1002/..
 
?
5

Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatiti..:

Li, Michael ; Wong, Danny ; Sack, Jordan S....
Clinical Gastroenterology and Hepatology.  22 (2024)  7 - p. 1444-1452.e4 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Safety, pharmacokinetics, pharmacodynamics, and antitumor a..:

Baranda, Joaquina C. ; Robbrecht, Debbie ; Sullivan, Ryan...
Clinical and Translational Science.  17 (2024)  6 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
7

Correction: Combination of Itacitinib or Parsaclisib with P..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications.  4 (2024)  3 - p. 785-785 , 2024
Link: https://doi.org/10.1158/..
 
?
8

A phase Ib trial of combined PKC and MEK inhibition with so..:

Bauer, Sebastian ; Larkin, James ; Hodi, F. Stephen...
Frontiers in Oncology.  12 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

First-in-human phase I study of the OX40 agonist GSK3174998..:

Postel-Vinay, Sophie ; Lam, Vincent K ; Ros, Willeke...
Journal for ImmunoTherapy of Cancer.  11 (2023)  3 - p. e005301 , 2023
Link: https://doi.org/10.1136/..
 
?
10

Liquid biopsy epigenomic profiling for cancer subtyping:

Baca, Sylvan C. ; Seo, Ji-Heui ; Davidsohn, Matthew P....
Nature Medicine.  29 (2023)  11 - p. 2737-2741 , 2023
Link: https://doi.org/10.1038/..
 
?
11

Granulocyte–Macrophage Colony-Stimulating Factor Influence ..:

Li, Xiaoyu ; Li, Jingjing ; Zheng, Yue...
Cancer Immunology Research.  11 (2023)  8 - p. 1100-1113 , 2023
Link: https://doi.org/10.1158/..
 
?
12

Infliximab for Steroid-Refractory Immune Checkpoint Inhibit..:

Townsend, Matthew J. ; Hodi, F. Stephen ; Grover, Shilpa
ACG Case Reports Journal.  10 (2023)  3 - p. e01018 , 2023
Link: https://doi.org/10.14309..
 
?
13

Combination of Itacitinib or Parsaclisib with Pembrolizumab..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications.  3 (2023)  12 - p. 2572-2584 , 2023
Link: https://doi.org/10.1158/..
 
?
14

Author Correction: Liquid biopsy epigenomic profiling for c..:

Baca, Sylvan C. ; Seo, Ji-Heui ; Davidsohn, Matthew P....
Nature Medicine.  30 (2023)  3 - p. 907-907 , 2023
Link: https://doi.org/10.1038/..
 
?
15

Mechanisms of response and resistance to combined decitabin..:

Penter, Livius ; Liu, Yang ; Wolff, Jacquelyn O....
Blood.  141 (2023)  15 - p. 1817-1830 , 2023
Link: https://doi.org/10.1182/..
 
1-15